Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis

A Corrigendum to this article was published on 24 October 2012

This article has been updated

Abstract

Circulating tumour cells (CTCs) shed into blood from primary cancers include putative precursors that initiate distal metastases1. Although these cells are extraordinarily rare, they may identify cellular pathways contributing to the blood-borne dissemination of cancer. Here, we adapted a microfluidic device2 for efficient capture of CTCs from an endogenous mouse pancreatic cancer model3 and subjected CTCs to single-molecule RNA sequencing4, identifying Wnt2 as a candidate gene enriched in CTCs. Expression of WNT2 in pancreatic cancer cells suppresses anoikis, enhances anchorage-independent sphere formation, and increases metastatic propensity in vivo. This effect is correlated with fibronectin upregulation and suppressed by inhibition of MAP3K7 (also known as TAK1) kinase. In humans, formation of non-adherent tumour spheres by pancreatic cancer cells is associated with upregulation of multiple WNT genes, and pancreatic CTCs revealed enrichment for WNT signalling in 5 out of 11 cases. Thus, molecular analysis of CTCs may identify candidate therapeutic targets to prevent the distal spread of cancer.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Analysis of mouse pancreatic CTCs identifies Wnt2 as a candidate CTC gene.
Figure 2: WNT2 promotes anchorage-independent cell survival and pancreatic cancer cell metastasis.
Figure 3: Association of WNT2-prosurvival phenotype with non-canonical WNT signalling and inhibition by suppression of MAP3K7 (TAK1).
Figure 4: Detection of WNT2 mRNA expression and non-canonical WNT signature in human pancreatic CTCs.

Similar content being viewed by others

Change history

  • 24 October 2012

    Nature 487, 510–513 (2012); doi:10.1038/nature11217 In this Letter, we omitted the following accession information. The digital gene expression matrix and the Helicos single-molecule sequence data from which it was derived are available at the NCBI GEO database with accession number GSE40176. A total of 44 samples were uploaded including 12 mouse and 32 human samples.

References

  1. Yu, M., Stott, S., Toner, M., Maheswaran, S. & Haber, D. A. Circulating tumor cells: approaches to isolation and characterization. J. Cell Biol. 192, 373–382 (2011)

    Article  CAS  Google Scholar 

  2. Stott, S. L. et al. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc. Natl Acad. Sci. USA 107, 18392–18397 (2010)

    Article  ADS  CAS  Google Scholar 

  3. Bardeesy, N. et al. Both p16Ink4a and the p19Arf-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse. Proc. Natl Acad. Sci. USA 103, 5947–5952 (2006)

    Article  ADS  CAS  Google Scholar 

  4. Ozsolak, F. et al. Amplification-free digital gene expression profiling from minute cell quantities. Nature Methods 7, 619–621 (2010)

    Article  CAS  Google Scholar 

  5. Wang, L., Feng, Z., Wang, X. & Zhang, X. DEGseq: an R package for identifying differentially expressed genes from RNA-seq data. Bioinformatics 26, 136–138 (2010)

    Article  Google Scholar 

  6. Ting, D. T. et al. Aberrant overexpression of satellite repeats in pancreatic and other epithelial cancers. Science 331, 593–596 (2011)

    Article  ADS  CAS  Google Scholar 

  7. Reynolds, B. A. & Weiss, S. Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. Dev. Biol. 175, 1–13 (1996)

    Article  CAS  Google Scholar 

  8. Dontu, G. et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 17, 1253–1270 (2003)

    Article  CAS  Google Scholar 

  9. Katoh, M. WNT signaling pathway and stem cell signaling network. Clin. Cancer Res. 13, 4042–4045 (2007)

    Article  CAS  Google Scholar 

  10. Hoshida, Y. et al. Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. Cancer Res. 69, 7385–7392 (2009)

    Article  CAS  Google Scholar 

  11. Ninomiya-Tsuji, J. et al. A resorcylic acid lactone, 5Z–7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase. J. Biol. Chem. 278, 18485–18490 (2003)

    Article  CAS  Google Scholar 

  12. Bowers, J. et al. Virtual terminator nucleotides for next-generation DNA sequencing. Nature Methods 6, 593–595 (2009)

    Article  CAS  Google Scholar 

  13. Ozsolak, F. et al. Digital transcriptome profiling from attomole-level RNA samples. Genome Res. 20, 519–525 (2010)

    Article  CAS  Google Scholar 

  14. Lipson, D. et al. Quantification of the yeast transcriptome by single-molecule sequencing. Nature Biotechnol. 27, 652–658 (2009)

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank C. Koris and the MGH clinical research coordinators for help with clinical studies, J. Gentry for computer informatics support, L. Libby for mouse studies, J. Walsh for microscopy expertise, Z. Nakamura for technical support, D. Jones for sequencing, and M. Rivera and S. Akhavanfard for RNA-ISH. This work was supported by Stand Up To Cancer (D.A.H., M.T., S.M.), Howard Hughes Medical Institute (D.A.H.), NIBIB Quantum Grant 5R01EB008047 (M.T.), NIH CA129933 (D.A.H.), Pancreatic Cancer Action Network – AACR Fellowship (D.T.T.), the Warshaw Institute for Pancreatic Cancer Research (D.T.T.), and the K12 Paul Calabresi Award for Clinical Oncology Clinical Research Career Development Program NIH 5K12CA87723-09 (D.T.T.).

Author information

Authors and Affiliations

Authors

Contributions

M.Y., D.T.T., S.M. and D.A.H. designed and conducted the study, analysed data, and prepared the manuscript. S.L.S. and M.T. contributed to the microfluidic system. D.T.T., B.S.W., F.O., B.W.B. and P.M.M. performed Helicos digital gene expression analysis. B.S.W. and S.R. performed bioinformatic and statistical analysis. S.P., J.C.C., M.E.S., D.W., A.J.G., M.J.U. and K.X. provided technical assistance for microfluidic experiments. M.Y., D.T.T., B.W.B. and J.C.C. performed RNA-ISH analysis. D.T.T., D.P.R. and L.V.S. acquired clinical samples. G.C., B.A. and N.B. provided the mouse model and cell line. S.L.S., B.S.W., P.M.M., S.R. and M.T. commented on the manuscript.

Corresponding authors

Correspondence to Shyamala Maheswaran or Daniel A. Haber.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Information

This file contains Supplementary Figures 1-17 and Supplementary Tables 1-12. (PDF 13562 kb)

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yu, M., Ting, D., Stott, S. et al. RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis. Nature 487, 510–513 (2012). https://doi.org/10.1038/nature11217

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nature11217

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer